According to Foster City, Calif.-based Gilead, Vemlidy is the first drug approved to treat this disease in almost a decade.
Vemlidy demonstrates similar antiviral efficacy at a dose one-tenth the size of Gilead’s other hepatitis B drug Viread, which gained FDA approval in 2001.
More articles on supply chain:
Trucking industry hopeful Trump will loosen regulations, increase road spending
Leverage data analytics to control cath lab costs
FDA updates citizen petition regulations to prevent delays in drug approvals